Mobilization of Stem Cells With Motixafortide (BL-8040) in Combination With G-CSF in Multiple Myeloma Patients

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(2 sites)

China

Peking University People's Hospital, Beijing, Beijing Municipality

Harbin The First Hospital, Harbin, Hei Longjiang